These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29785036)

  • 1. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy.
    Fu Q; Yang F; Xiang T; Huai G; Yang X; Wei L; Yang H; Deng S
    Sci Rep; 2018 May; 8(1):7933. PubMed ID: 29785036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    Zhang J; Chong CC; Chen GG; Lai PB
    PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
    Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
    J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
    Lin Z; Cai YJ; Chen RC; Chen BC; Zhao L; Xu SH; Wang XD; Song M; Wu JM; Wang YQ; Zhou MT; Shi KQ
    Clin Chim Acta; 2017 Jun; 469():171-179. PubMed ID: 28365450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma.
    Qin L; Huang J; Wang G; Huang J; Wu X; Li J; Yi W; Qin F; Huang D
    J Cell Physiol; 2019 Dec; 234(12):23581-23595. PubMed ID: 31210353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
    Li MM; Tang YQ; Gong YF; Cheng W; Li HL; Kong FE; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
    BMC Cancer; 2019 Aug; 19(1):851. PubMed ID: 31462277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
    Wang X; Zeng J; Wang L; Zhang X; Liu Z; Zhang H; Dong J
    Oncol Rep; 2017 Jul; 38(1):141-150. PubMed ID: 28586051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma.
    Wei R; Huang GL; Zhang MY; Li BK; Zhang HZ; Shi M; Chen XQ; Huang L; Zhou QM; Jia WH; Zheng XF; Yuan YF; Wang HY
    Clin Cancer Res; 2013 Sep; 19(17):4780-91. PubMed ID: 23812667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
    Guan Z; Cheng W; Huang D; Wei A
    Curr Res Transl Med; 2018 Mar; 66(1):27-32. PubMed ID: 29274707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y
    Life Sci; 2020 Nov; 260():118396. PubMed ID: 32918973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.